Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study-Reference-Cited by-同舟云学术

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Published:2022-04 Issue:10335 Volume:399 Page:1618-1624
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Menni Cristina,Valdes Ana M,Polidori Lorenzo,Antonelli Michela,Penamakuri Satya,Nogal Ana,Louca Panayiotis,May Anna,Figueiredo Jane C,Hu Christina,Molteni Erika,Canas Liane,Österdahl Marc F,Modat Marc,Sudre Carole H,Fox Ben,Hammers Alexander,Wolf Jonathan,Capdevila Joan,Chan Andrew T,David Sean P,Steves Claire J,Ourselin Sebastien,Spector Tim D

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Increased immune escape of the new SARS-CoV-2 variant of concern omicron;Hu;Cell Mol Immunol,2022

2. Clinical characteristics of 40 patients infected with the SARS-CoV-2 omicron variant in Korea;Kim;J Korean Med Sci,2022

3. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study;Wolter;Lancet,2022

4. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves;Maslo;JAMA,2022

5. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa;Davies;medRxiv,2022

Cited by 528 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza and Viral Pneumonia;Infectious Disease Clinics of North America;2024-03

2. Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China;JMIR Public Health and Surveillance;2024-02-05

3. Quantitative and qualitative subgenomic RNA profiles of SARS-CoV-2 in respiratory samples: a comparison between Omicron BA.2 and non-VOC-D614G;Virologica Sinica;2024-02

4. Acute and persistent symptoms of COVID-19 infection in school-aged children: a retrospective study from China;BMC Public Health;2024-02-01

5. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study;The Lancet Infectious Diseases;2024-02